• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从真菌提取物文库中寻找天然产物抗利什曼原虫药物。

Mining for natural product antileishmanials in a fungal extract library.

机构信息

Department of Biosciences and Centre for Global Infectious Diseases, Durham University, Stockton Road, Durham, DH1 3LE, UK.

Glasgow Polyomics, College of Medical, Veterinary & Life Sciences, University of Glasgow, Garscube Estate, Bearsden, Glasgow, G61 1QH, UK.

出版信息

Int J Parasitol Drugs Drug Resist. 2019 Dec;11:118-128. doi: 10.1016/j.ijpddr.2019.05.003. Epub 2019 Jun 11.

DOI:10.1016/j.ijpddr.2019.05.003
PMID:31208892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6904819/
Abstract

Leishmaniasis is a Neglected Tropical Disease caused by the insect-vector borne protozoan parasite, Leishmania species. Infection affects millions of the World's poorest, however vaccines are absent and drug therapy limited. Recently, public-private partnerships have developed to identify new modes of controlling leishmaniasis. Most of these collaborative efforts have relied upon the small molecule synthetic compound libraries held by industry, but the number of New Chemical Entities (NCE) identified and entering development as antileishmanials has been very low. In light of this, here we describe a public-private effort to identify natural products with activity against Leishmania mexicana, a causative agent of cutaneous leishmanaisis (CL). Utilising Hypha Discovery's fungal extract library which is rich in small molecule (<500 molecular weight) secondary metabolites, we undertook an iterative phenotypic screening and fractionation approach to identify potent and selective antileishmanial hits. This led to the identification of a novel oxidised bisabolane sesquiterpene which demonstrated activity in an infected cell model and was shown to disrupt multiple processes using a metabolomic approach. In addition, and importantly, this study also sets a precedent for new approaches for CL drug discovery.

摘要

利什曼病是一种由昆虫媒介传播的原生动物寄生虫利什曼原虫引起的被忽视的热带病。感染影响了世界上最贫穷的数百万人,但目前没有疫苗,药物治疗也很有限。最近,公私合作伙伴关系已经发展起来,以确定控制利什曼病的新方法。这些合作努力大多依赖于行业持有的小分子合成化合物库,但作为抗利什曼病药物被鉴定和进入开发的新化学实体 (NCE) 的数量非常低。有鉴于此,在这里,我们描述了一项公私合作努力,旨在鉴定对导致皮肤利什曼病 (CL) 的利什曼原虫有活性的天然产物。利用 Hypha Discovery 富含小分子 (<500 分子量) 次生代谢物的真菌提取物文库,我们采用迭代表型筛选和分馏方法来鉴定有效的和选择性的抗利什曼原虫化合物。这导致了一种新型氧化倍半萜类化合物的鉴定,该化合物在感染细胞模型中表现出活性,并通过代谢组学方法显示出破坏多种过程的能力。此外,重要的是,这项研究还为 CL 药物发现的新方法奠定了先例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b004/6904819/017847f34d57/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b004/6904819/ba94ea417cc4/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b004/6904819/4a56ceebe9e4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b004/6904819/4879d04b2925/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b004/6904819/a8225d00e39b/gr3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b004/6904819/842b57675912/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b004/6904819/0b20554fd4bb/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b004/6904819/f4c63673a427/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b004/6904819/017847f34d57/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b004/6904819/ba94ea417cc4/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b004/6904819/4a56ceebe9e4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b004/6904819/4879d04b2925/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b004/6904819/a8225d00e39b/gr3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b004/6904819/842b57675912/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b004/6904819/0b20554fd4bb/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b004/6904819/f4c63673a427/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b004/6904819/017847f34d57/gr7.jpg

相似文献

1
Mining for natural product antileishmanials in a fungal extract library.从真菌提取物文库中寻找天然产物抗利什曼原虫药物。
Int J Parasitol Drugs Drug Resist. 2019 Dec;11:118-128. doi: 10.1016/j.ijpddr.2019.05.003. Epub 2019 Jun 11.
2
Identifying inhibitors of the Leishmania inositol phosphorylceramide synthase with antiprotozoal activity using a yeast-based assay and ultra-high throughput screening platform.利用酵母基础测定法和超高速筛选平台鉴定具有抗原生动物活性的莱什曼原虫肌醇磷酸神经酰胺合酶抑制剂。
Sci Rep. 2018 Mar 2;8(1):3938. doi: 10.1038/s41598-018-22063-9.
3
An Update on Natural Antileishmanial Treatment Options from Plants, Fungi and Algae.植物、真菌和藻类天然抗利什曼原虫治疗方法的最新进展。
Chem Biodivers. 2022 Jan;19(1):e202100542. doi: 10.1002/cbdv.202100542. Epub 2021 Dec 22.
4
Screening a Natural Product-Based Library against Kinetoplastid Parasites.抗锥虫天然产物文库的筛选。
Molecules. 2017 Oct 12;22(10):1715. doi: 10.3390/molecules22101715.
5
High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.用于发现抗三种被忽视热带病(人类非洲锥虫病、利什曼病和恰加斯病)的天然产物药物的高通量筛选平台。
J Biomol Screen. 2015 Jan;20(1):82-91. doi: 10.1177/1087057114555846. Epub 2014 Oct 20.
6
An investigation of the antileishmanial properties of semi-synthetic saponins.半合成皂苷的抗利什曼原虫特性研究。
RSC Med Chem. 2020 Jun 9;11(7):833-842. doi: 10.1039/d0md00123f. eCollection 2020 Jul 1.
7
Antileishmanial Activity of Compounds Derived from the Medicines for Malaria Venture Open Access Box Against Intracellular Leishmania major Amastigotes.疟疾药物研发风险公开获取药盒中衍生化合物对细胞内硕大利什曼原虫无鞭毛体的抗利什曼活性
Am J Trop Med Hyg. 2016 Feb;94(2):340-347. doi: 10.4269/ajtmh.15-0448. Epub 2015 Oct 26.
8
Harnessing computational and experimental approaches to identify potent hits against Leishmania donovani sterol C-24 methyltransferase from ChemBridge library.利用计算和实验方法从ChemBridge文库中鉴定针对杜氏利什曼原虫甾醇C-24甲基转移酶的有效活性成分。
Acta Trop. 2024 Dec;260:107473. doi: 10.1016/j.actatropica.2024.107473. Epub 2024 Nov 15.
9
Development of a target-free high-throughput screening platform for the discovery of antileishmanial compounds.开发一种无靶标高通量筛选平台,用于发现抗利什曼原虫化合物。
Int J Antimicrob Agents. 2019 Oct;54(4):496-501. doi: 10.1016/j.ijantimicag.2019.07.013. Epub 2019 Jul 16.
10
Design and Application of a High-Throughput, High-Content Screening System for Natural Product Inhibitors of the Human Parasite .一种用于人类寄生虫天然产物抑制剂的高通量、高内涵筛选系统的设计与应用
ACS Infect Dis. 2019 Aug 9;5(8):1456-1470. doi: 10.1021/acsinfecdis.9b00156. Epub 2019 Jul 2.

引用本文的文献

1
Drug Discovery for Cutaneous Leishmaniasis: A Review of Developments in the Past 15 Years.皮肤利什曼病的药物研发:过去15年进展综述
Microorganisms. 2023 Nov 23;11(12):2845. doi: 10.3390/microorganisms11122845.
2
PeakBot: machine-learning-based chromatographic peak picking.PeakBot:基于机器学习的色谱峰提取。
Bioinformatics. 2022 Jun 27;38(13):3422-3428. doi: 10.1093/bioinformatics/btac344.
3
Chalcones identify cTXNPx as a potential antileishmanial drug target.查耳酮将 cTXNPx 鉴定为一种潜在的抗利什曼原虫药物靶点。

本文引用的文献

1
Active Natural Product Scaffolds against Trypanosomatid Parasites: A Review.抗锥虫寄生虫的天然活性产物骨架:综述。
J Nat Prod. 2018 Sep 28;81(9):2138-2154. doi: 10.1021/acs.jnatprod.8b00159. Epub 2018 Sep 20.
2
Leishmaniasis.利什曼病。
Lancet. 2018 Sep 15;392(10151):951-970. doi: 10.1016/S0140-6736(18)31204-2. Epub 2018 Aug 17.
3
Deletion of transketolase triggers a stringent metabolic response in promastigotes and loss of virulence in amastigotes of Leishmania mexicana.转酮醇酶缺失可引发墨西哥利什曼原虫前鞭毛体的严格代谢反应和无鞭毛体毒力丧失。
PLoS Negl Trop Dis. 2021 Nov 15;15(11):e0009951. doi: 10.1371/journal.pntd.0009951. eCollection 2021 Nov.
4
An investigation of the antileishmanial properties of semi-synthetic saponins.半合成皂苷的抗利什曼原虫特性研究。
RSC Med Chem. 2020 Jun 9;11(7):833-842. doi: 10.1039/d0md00123f. eCollection 2020 Jul 1.
5
Experimental Strategies to Explore Drug Action and Resistance in Kinetoplastid Parasites.探索动基体寄生虫药物作用及耐药性的实验策略
Microorganisms. 2020 Jun 24;8(6):950. doi: 10.3390/microorganisms8060950.
PLoS Pathog. 2018 Mar 19;14(3):e1006953. doi: 10.1371/journal.ppat.1006953. eCollection 2018 Mar.
4
Identifying inhibitors of the Leishmania inositol phosphorylceramide synthase with antiprotozoal activity using a yeast-based assay and ultra-high throughput screening platform.利用酵母基础测定法和超高速筛选平台鉴定具有抗原生动物活性的莱什曼原虫肌醇磷酸神经酰胺合酶抑制剂。
Sci Rep. 2018 Mar 2;8(1):3938. doi: 10.1038/s41598-018-22063-9.
5
Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art.重新利用作为发现新型抗利什曼原虫药物的策略:最新进展
Parasitology. 2018 Feb;145(2):219-236. doi: 10.1017/S0031182017000993. Epub 2017 Aug 14.
6
Functional and genetic evidence that nucleoside transport is highly conserved in Leishmania species: Implications for pyrimidine-based chemotherapy.功能和遗传学证据表明核苷转运在利什曼原虫物种中高度保守:对基于嘧啶的化疗的影响。
Int J Parasitol Drugs Drug Resist. 2017 Aug;7(2):206-226. doi: 10.1016/j.ijpddr.2017.04.003. Epub 2017 Apr 20.
7
Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness.蛋白酶体抑制用于治疗利什曼病、恰加斯病和昏睡病。
Nature. 2016 Sep 8;537(7619):229-233. doi: 10.1038/nature19339. Epub 2016 Aug 8.
8
A role for adenine nucleotides in the sensing mechanism to purine starvation in Leishmania donovani.腺嘌呤核苷酸在杜氏利什曼原虫嘌呤饥饿感应机制中的作用。
Mol Microbiol. 2016 Jul;101(2):299-313. doi: 10.1111/mmi.13390. Epub 2016 May 3.
9
New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource.从针对三种动基体寄生虫的高通量表型筛选中鉴定出的新化合物集:一种开放资源。
Sci Rep. 2015 Mar 5;5:8771. doi: 10.1038/srep08771.
10
Investigating the anti-leishmanial effects of linear peptoids.研究线性类肽的抗利什曼原虫作用。
ChemMedChem. 2015 Feb;10(2):233-7. doi: 10.1002/cmdc.201402416. Epub 2014 Dec 15.